Leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs will discuss the challenges associated with the discovery and validation of biomarkers for autism, Parkinson's disease, Alzheimer's disease, multiple sclerosis and schizophrenia.
More information may be found at https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=303 . A draft program is attached.
Tel: + 44 (0) 1223 495100
Email: l [dot] criddle [ at ] hinxton [dot] wellcome [dot] ac [dot] uk
|Draftprogramme2013.pdf ||356.31 KB|